原發(fā)性腹膜癌24例病例分析.pdf

1、大連醫(yī)科大學(xué)碩士學(xué)位論文原發(fā)性腹膜癌24例病例分析姓名：劉莉娟申請(qǐng)學(xué)位級(jí)別：碩士專業(yè)：婦產(chǎn)科學(xué)指導(dǎo)教師：孔繁斗20090601ClinicalAnalysisof24PatientswithDrlmaryPeritonealCarcinomaIL一一一—Masterdegreecandidate：LiuLijuanSupervisor：KongFan—douVice—supervisor：ShihongMajor：obstetricsa

2、ndgynecologyAbstractObjective：PrimaryperitonealcarcinomaisamalignanttumorwithlowincidenceandhighmisdiagnosisrateThispaperanalyzedtheelinicaIcharacteristics，diagnosis，treatment，andprognosisofprimarymalignantperitonealcarc

3、inomataisedtheawarenessofthisdiseaseMethods：Toanalyzedretrospectivelyclinicaldataof24caseswhichdiagnosiswasprimaryperitonealcarcinomainourhospitalbetweenFebruary2002andJFebruary2009Results：Inthisgroup，confirmedbypatholog

4、y：Primaryperitonealseropapillaryadenocareinomawere16cases，Krukenbergtumorwere2cases，Transitionalcellcarcinomawas1cases，the5casesthroughascitesCytologicalexaminationrevealedadenocarcinomacells，combinedwithauxiliaryexamina

5、tionconfirmedthediagnosis，withoutsurgicaltreatmentTheagesofPatientswere30to79yearsold，medianagewere56YearsoldPostoperativechemotherapyschemewascombinationchemotherapythatplatinum_basedSurvivaltimeofpatientswere3to47month

6、s，mediansurvivaltimewere17monthsConclusions：Theknowledgeoftheclinicalcharacteristicsofprimaryperitonealcarcinomashouldberaised，thediagnosisshouldbeclearedassoonaspossible，tumorcellcytoreductivesurgeryshouldbeperformedtim

7、ely，thescopeofsurgeryshouldnotbeoveremphasized，eombinedwiththeactualsituation，patientsshouldbegivencombinationehemotherapythatplatinumbasedtimely，sufficientdose，adequatetreatment，toimprovepatient’Ssurvivalrateandimprovet